Health Catalyst, Inc. (HCAT)
HCAT Stock Price Chart
Explore Health Catalyst, Inc. interactive price chart. Choose custom timeframes to analyze HCAT price movements and trends.
HCAT Company Profile
Discover essential business fundamentals and corporate details for Health Catalyst, Inc. (HCAT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
25 Jul 2019
Employees
1.50k
Website
https://www.healthcatalyst.comCEO
Benjamin Albert
Description
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
HCAT Financial Timeline
Browse a chronological timeline of Health Catalyst, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.02, while revenue estimate is $68.97m.
Earnings released on 11 May 2026
EPS came in at $0.02 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $70.76m , beating expectations by +2.19%.
Earnings released on 12 Mar 2026
EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $74.68m , beating expectations by +0.96%.
Earnings released on 10 Nov 2025
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $76.32m , beating expectations by +3.03%.
Earnings released on 7 Aug 2025
EPS came in at $0.04 surpassing the estimated $0.03 by +33.33%, while revenue for the quarter reached $80.72m , missing expectations by -5.19%.
Earnings released on 7 May 2025
EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $79.41m , beating expectations by +0.32%.
Earnings released on 26 Feb 2025
EPS came in at $0.04 falling short of the estimated $0.11 by -63.64%, while revenue for the quarter reached $79.61m , beating expectations by +0.02%.
Earnings released on 6 Nov 2024
EPS came in at $0.07 falling short of the estimated $0.10 by -30.00%, while revenue for the quarter reached $76.35m , missing expectations by -5.37%.
Earnings released on 7 Aug 2024
EPS came in at $0.12 surpassing the estimated $0.09 by +33.33%, while revenue for the quarter reached $75.90m , beating expectations by +1.20%.
Earnings released on 9 May 2024
EPS came in at $0.05 surpassing the estimated $0.03 by +79.02%, while revenue for the quarter reached $74.72m , missing expectations by -0.10%.
Earnings released on 22 Feb 2024
EPS came in at $0.02 surpassing the estimated $0.00 by +2.72k%, while revenue for the quarter reached $75.08m , beating expectations by +2.02%.
Earnings released on 2 Nov 2023
EPS came in at $0.03 surpassing the estimated -$0.03 by +200.00%, while revenue for the quarter reached $73.77m , beating expectations by +1.00%.
Earnings released on 8 Aug 2023
EPS came in at $0.05 surpassing the estimated $0.00 by +1.45k%, while revenue for the quarter reached $73.21m , beating expectations by +0.80%.
Earnings released on 9 May 2023
EPS came in at $0.05 surpassing the estimated $0.02 by +222.79%, while revenue for the quarter reached $73.87m , beating expectations by +3.69%.
Earnings released on 28 Feb 2023
EPS came in at -$0.05 surpassing the estimated -$0.10 by +50.00%, while revenue for the quarter reached $69.16m , beating expectations by +1.32%.
Earnings released on 8 Nov 2022
EPS came in at -$0.13 surpassing the estimated -$0.20 by +35.00%, while revenue for the quarter reached $68.35m , beating expectations by +2.30%.
Earnings released on 4 Aug 2022
EPS came in at -$0.03 surpassing the estimated -$0.11 by +72.73%, while revenue for the quarter reached $70.63m , beating expectations by +1.08%.
Earnings released on 10 May 2022
EPS came in at -$0.06 surpassing the estimated -$0.08 by +25.00%, while revenue for the quarter reached $68.09m , beating expectations by +3.15%.
Earnings released on 1 Mar 2022
EPS came in at -$0.19 surpassing the estimated -$0.21 by +9.52%, while revenue for the quarter reached $64.72m , beating expectations by +2.53%.
Earnings released on 9 Nov 2021
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%, while revenue for the quarter reached $61.74m , beating expectations by +2.10%.
Earnings released on 5 Aug 2021
EPS came in at -$0.80 falling short of the estimated -$0.14 by -470.24%, while revenue for the quarter reached $59.63m , beating expectations by +4.46%.
HCAT Stock Performance
Access detailed HCAT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
